MyAverix Finance
TWO · Healthcare
Handa Pharmaceuticals Inc. (6620)
Drug Manufacturers - Specialty & Generic
Handa Pharmaceuticals Inc. (6620) is listed on TWO in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 6620
Handa Pharmaceuticals Inc. (6620) — FAQ
What is 6620's P/E ratio?
The price-to-earnings (P/E) ratio for Handa Pharmaceuticals Inc. (6620) is 18.00 (data as of 2026-03-23).
Does Handa Pharmaceuticals Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Handa Pharmaceuticals Inc. (6620). Check the MyAverix Finance app for the latest dividend data.
What sector is Handa Pharmaceuticals Inc. in?
Handa Pharmaceuticals Inc. (6620) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 6620 listed on?
6620 is listed on TWO.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.